Faulty immune system may lead to lung cancer

Faulty immune system may lead to lung cancer

An immune system that's not functioning normally may lead to lung cancer in patients who don't smoke, a new study suggests.

"A strong helps to keep inflammation under control and is known to promote cancer," said co-author Rayjean Hung.

"Our research suggests that it's underlying dysfunction of immune regulation that can lead to , as if a shield is down," she said. Hung is a senior investigator at Sinai Health's Lunenfeld-Tanenbaum Research Institute in Toronto.

For the study, Hung's team looked at the genes of 80,000 people to see if conditions other than those that compromise lung function—such as (COPD)—can cause lung cancer. As many as 70% of lung cancer patients also have existing COPD or airflow obstruction.

"Who suffers from lung cancer goes beyond what could be explained by smoking," Hung said. "Our findings provide more insight on why lung cancer occurs in nonsmokers and points to the importance of immune regulation."

Screening CT scans can find lung cancer before symptoms appear. Finding the disease early can make curing it more likely. These findings expand the number of people who should be screened, the researchers said.

The report was published online recently in the journal Nature Communications.

Explore further

Lung cancer screening can detect other smoking ills

More information: For more on lung cancer, head to the American Cancer Society.
Journal information: Nature Communications

Copyright © 2020 HealthDay. All rights reserved.

Citation: Faulty immune system may lead to lung cancer (2020, January 24) retrieved 17 January 2021 from https://medicalxpress.com/news/2020-01-faulty-immune-lung-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments